SeaSpine Holdings Co. Expected to Post FY2022 Earnings of ($0.89) Per Share (NASDAQ:SPNE)

SeaSpine Holdings Co. (NASDAQ:SPNEGet Rating) – Equities researchers at Cantor Fitzgerald issued their FY2022 earnings estimates for SeaSpine in a research report issued to clients and investors on Tuesday, April 12th. Cantor Fitzgerald analyst R. Osborn forecasts that the medical equipment provider will post earnings of ($0.89) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating on the stock.

SeaSpine (NASDAQ:SPNEGet Rating) last posted its quarterly earnings results on Friday, March 11th. The medical equipment provider reported ($0.52) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.34) by ($0.18). SeaSpine had a negative net margin of 28.39% and a negative return on equity of 21.26%.

Several other equities research analysts have also weighed in on SPNE. Truist Financial dropped their target price on SeaSpine from $25.00 to $20.00 and set a “buy” rating on the stock in a research report on Tuesday, December 21st. Zacks Investment Research lowered SeaSpine from a “buy” rating to a “hold” rating in a research report on Saturday, January 29th. Stifel Nicolaus dropped their target price on SeaSpine from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Monday, March 14th. Piper Sandler dropped their target price on SeaSpine from $28.00 to $21.00 and set an “overweight” rating on the stock in a research report on Monday, March 14th. Finally, StockNews.com started coverage on SeaSpine in a research report on Thursday, March 31st. They issued a “hold” rating on the stock. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $32.00.

SPNE stock opened at $10.74 on Friday. The firm has a market cap of $395.12 million, a P/E ratio of -6.63 and a beta of 1.19. SeaSpine has a 12-month low of $10.66 and a 12-month high of $22.78. The stock’s 50 day simple moving average is $11.84 and its 200 day simple moving average is $13.16.

Institutional investors and hedge funds have recently modified their holdings of the company. HighTower Advisors LLC increased its holdings in shares of SeaSpine by 12.8% during the third quarter. HighTower Advisors LLC now owns 96,162 shares of the medical equipment provider’s stock valued at $1,511,000 after purchasing an additional 10,896 shares during the period. Rothschild & Co. Asset Management US Inc. increased its holdings in shares of SeaSpine by 16.3% during the third quarter. Rothschild & Co. Asset Management US Inc. now owns 74,368 shares of the medical equipment provider’s stock valued at $1,170,000 after purchasing an additional 10,423 shares during the period. MFA Wealth Advisors LLC bought a new position in SeaSpine during the third quarter valued at about $71,000. Moors & Cabot Inc. bought a new position in SeaSpine during the third quarter valued at about $4,874,000. Finally, BlackRock Inc. boosted its stake in SeaSpine by 0.5% during the third quarter. BlackRock Inc. now owns 2,415,642 shares of the medical equipment provider’s stock valued at $37,998,000 after buying an additional 13,132 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

About SeaSpine (Get Rating)

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine.

Further Reading

Earnings History and Estimates for SeaSpine (NASDAQ:SPNE)

Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.